| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| GLAZER CAPITAL, LLC | 4.6% | $11,829,640 | 2,474,820 | Glazer Capital, LLC | 02 Sep 2025 | |||
| KING LUTHER CAPITAL MANAGEMENT CORP | 4% | -43% | $11,982,841 | -$8,674,586 | 2,128,391 | -42% | Luther King Capital Management Corporation | 30 Sep 2025 |
As of 31 Dec 2025, 0 institutional investors reported holding 0 shares of scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share (SCPH). This represents 0% of the company’s total 53,364,241 outstanding shares.
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 0 | $0 | -$221,264,031 | $5.67 | 0 |
| 2025 Q3 | 40,958,051 | $232,212,551 | +$31,413,737 | $5.67 | 108 |
| 2025 Q2 | 38,194,973 | $145,545,847 | +$3,415,856 | $3.81 | 95 |
| 2025 Q1 | 37,545,308 | $98,742,458 | -$7,793,831 | $2.63 | 87 |
| 2024 Q4 | 39,775,602 | $140,807,820 | +$5,279,129 | $3.54 | 84 |
| 2024 Q3 | 37,253,566 | $169,822,547 | +$42,711,046 | $4.56 | 93 |
| 2024 Q2 | 27,815,340 | $121,012,490 | +$4,504,277 | $4.35 | 77 |
| 2024 Q1 | 26,737,974 | $134,225,727 | -$7,908,753 | $5.02 | 76 |
| 2023 Q4 | 27,975,859 | $175,412,395 | -$21,478,357 | $6.27 | 79 |
| 2023 Q3 | 29,932,073 | $213,117,843 | +$9,111,651 | $7.12 | 73 |
| 2023 Q2 | 28,536,920 | $290,787,599 | +$40,687,005 | $10.19 | 81 |
| 2023 Q1 | 24,606,169 | $223,185,472 | +$38,842,993 | $9.07 | 63 |
| 2022 Q4 | 21,410,510 | $153,514,412 | +$53,537,608 | $7.17 | 59 |
| 2022 Q3 | 14,022,022 | $91,281,927 | -$10,765,163 | $6.52 | 38 |
| 2022 Q2 | 15,695,145 | $75,930,511 | -$3,255,361 | $4.82 | 37 |
| 2022 Q1 | 15,882,655 | $90,121,602 | -$464,823 | $5.68 | 34 |
| 2021 Q4 | 15,935,241 | $79,992,923 | -$1,598,866 | $5.02 | 29 |
| 2021 Q3 | 16,228,718 | $107,917,705 | +$1,557,655 | $6.65 | 29 |
| 2021 Q2 | 16,027,286 | $97,921,582 | -$7,160,512 | $6.11 | 35 |
| 2021 Q1 | 17,151,321 | $114,054,500 | +$1,499,774 | $6.65 | 45 |
| 2020 Q4 | 16,944,254 | $89,636,480 | -$6,272,494 | $5.29 | 46 |
| 2020 Q3 | 17,093,245 | $127,345,487 | -$3,281,426 | $7.45 | 48 |
| 2020 Q2 | 17,536,133 | $129,064,483 | +$37,153,425 | $7.36 | 51 |
| 2020 Q1 | 12,488,415 | $92,413,167 | +$10,168,930 | $7.40 | 32 |
| 2019 Q4 | 11,121,954 | $62,947,464 | +$1,581,064 | $5.65 | 27 |
| 2019 Q3 | 7,577,638 | $44,502,550 | +$1,469,868 | $5.89 | 24 |
| 2019 Q2 | 7,370,534 | $23,510,457 | -$286,179 | $3.19 | 28 |
| 2019 Q1 | 7,483,932 | $22,451,653 | -$1,275,253 | $3.00 | 32 |
| 2018 Q4 | 7,846,766 | $29,504,290 | -$830,389 | $3.76 | 32 |
| 2018 Q3 | 8,056,307 | $47,291,256 | -$192,971 | $5.87 | 31 |
| 2018 Q2 | 8,090,838 | $45,789,211 | -$6,149,684 | $5.66 | 37 |
| 2018 Q1 | 8,320,407 | $103,170,760 | +$6,465,196 | $12.40 | 37 |
| 2017 Q4 | 7,806,672 | $94,381,000 | +$94,381,000 | $12.09 | 24 |